WHR
64
3
BK
72
4
BMY
58
5
MCD
50
-2
NSC
57
7
STZ
57
2
RIG
58
4
SIG
49
6
ESS
64
4
ZTS
49
2
PEG
67
5
CAH
53
6
EMC
53
5
ABT
62
5
MRO
40
-15
A
41
5
KEY
43
3
PCAR
56
3
MMC
60
6
FOXA
59
4
WHR
64
3
BK
72
4
BMY
58
5
MCD
50
-2
NSC
57
7
STZ
57
2
RIG
58
4
SIG
49
6
ESS
64
4
ZTS
49
2
PEG
67
5
CAH
53
6
EMC
53
5
ABT
62
5
MRO
40
-15
A
41
5
KEY
43
3
PCAR
56
3
MMC
60
6
FOXA
59
4
Financhill
Back

Gilead Sciences 10K Form

Sell
49

GILD
Gilead Sciences

Last Price:
90.17
Seasonality Move:
7.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $4.17B
Price / Cash Flow: 11.91
Annual Sales: $14.83
Price / Book: 6.06

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $126M
Gross Margin: $20.62B
Return on Equity: 0.64%
Return on Assets: 0.22%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 1.26
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 19.95
Forward P/E Ratio: 11.99

GILD Technical Analysis vs Fundamental Analysis

Sell
49
Gilead Sciences (GILD) is a Sell

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Sell
    The current Gilead Sciences [GILD] share price is $89.76. The Score for GILD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.